1.
Systolic pressure is all that matters
by Williams, Bryan, Prof
The Lancet (British edition), 2008, Vol.371 (9631), p.2219-2221
2.
A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial
by Weber, Michael A, Prof
The Lancet (British edition), 2009, Vol.374 (9699), p.1423-1431
3.
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
by Dahlöf, Björn
The Lancet (British edition), 2002-03-23, Vol.359 (9311), p.995-1003
4.
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenol...
by Lindholm, Lars H
The Lancet (British edition), 2002-03-23, Vol.359 (9311), p.1004-1010
5.
Total cardiovascular risk approach to improve efficiency of cardiovascular prevention in resource constrain settings
by Mendis, Shanthi
Journal of clinical epidemiology, 2011, Vol.64 (12), p.1451-1462
6.
Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (C...
by Hansson, Lennart
The Lancet (British edition), 1999, Vol.353 (9153), p.611-616
7.
Prevention of cardiovascular disease in developing countries
by Lindholm, Lars H
The Lancet (British edition), 2007, Vol.370 (9589), p.720-722
8.
Blood-pressure drugs and cancer: much ado about nothing?
by Lindholm, Lars H
The lancet oncology, 2011, Vol.12 (1), p.6-8
9.
Blood-pressure-related disease is a global health priority
by MacMahon, Stephen
American journal of hypertension, 2008, Vol.371 (9623), p.1480-1482
10.
Divergent Results Using Clinic and Ambulatory Blood Pressures: Report of a Darusentan-Resistant Hypertension Trial
by Bakris, George L
Hypertension (Dallas, Tex. 1979), 2010-11, Vol.56 (5), p.824-830
11.
Effect of losartan on sudden cardiac death in people with diabetes: data from the LIFE study
by Lindholm, Lars H
The Lancet (British edition), 2003-08-23, Vol.362 (9384), p.619-620
12.
Greater Regression of Electrocardiographic Left Ventricular Hypertrophy During Hydrochlorothiazide Therapy in Hypertensive Patients
by Okin, Peter M.
American journal of hypertension, 2010-07, Vol.23 (7), p.786-793
13.
Relation between drug treatment and cancer in hypertensives in the Swedish Trial in Old Patients with hypertension 2: a 5-year, prospective, randomised, controlled trial
by LINDHOLM, Lars H
The Lancet (British edition), 2001, Vol.358 (9281), p.539-544
14.
Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study
by Ibsen, Hans
Hypertension (Dallas, Tex. 1979), 2005-02, Vol.45 (2), p.198-202
15.
Blood-pressure-related disease is a global health priority
by MacMahon, Stephen
American journal of hypertension, 2008-08, Vol.21 (8), p.843
16.
Blood-Pressure-Related Disease Is a Global Health Priority
by MacMahon, Stephen
American journal of hypertension, 2008-08, Vol.21 (8), p.843-844
17.
Valsartan treatment of hypertension—does VALUE add value?
by Lindholm, Lars H
The Lancet (British edition), 2004-06-19, Vol.363 (9426), p.2010-2011
18.
Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) s...
by Hansson, Lennart
The Lancet (British edition), 2000, Vol.356 (9227), p.359-365
19.
Combination of the Electrocardiographic Strain Pattern and Albuminuria for the Prediction of New-onset Heart Failure in Hypertensive Patients: The LIFE Study
by Okin, Peter M.
American journal of hypertension, 2008-03, Vol.21 (3), p.273-279
20.
Major benefits from cholesterol-lowering in patients with diabetes
by Lindholm, Lars H
The Lancet (British edition), 2003, Vol.361 (9374), p.2000-2001
